The BeVision M1 is an automated static image analyzer from Bettersize Instruments.
Bettersize Instruments’ BeVision M1 automated static image analyzer is an automated image scanning system suited to applications involving cleanliness analysis of particulates found on filters.
The BeVision M1 is an integral part of surface cleanliness measurements. Its many features and benefits include:Results compliant with ISO 9276-6An automatic sample stage that offers high position accuracyAdvantages of Using the Image Analysis Method This data can be summed up in statistical form to provide an accurate and detailed distribution of particle shape or size.
The BeVision software can also display real-time results during the scanning process. The instrument’s scanning mode is widely used in a range of industries due to its efficiency and reliability. When compared to manual testing, this automatic scanning process offers greater efficiency as it performs the image capturing and stage moving processes simultaneously.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
I live in a tiny caravan with my partner and dog – it’s so cheap but trolls say it’s no ‘decent’ way to liv...Living in a Static Caravan: An Affordable Home Alternative
Read more »
Automated prediction of Alzheimer's disease progression using speech and machine learningTrying to figure out whether someone has Alzheimer's disease usually involves a battery of assessments-;interviews, brain imaging, blood and cerebrospinal fluid tests.
Read more »
Advances in automated mass photometryThis article talks about the advances in automated mass photometry.
Read more »
Advances in automated mass photometryThis article talks about the advances in automated mass photometry.
Read more »
Future Labs Live Basel 2024: Digital, Automated, ConnectedFuture Labs Live is the leading global event for innovation and technology, serving as a dynamic platform for industry leaders, innovators, and enthusiasts to engage in discussions, share insights, and foster collaborations that will drive technological advancements.
Read more »
Cellular Origins acquires Actia Platform IP to enhance automated cell therapy manufacturingCellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), today announced the acquisition of the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge whilst CEO of SOTIO Biotech US.
Read more »